If you liked this article you might like

Teva Pharmaceutical Is Down to Key Support. Did I Say Key?
Questions Mount at Teva as Generics Head Quits Without Explanation
Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
Some 'January Effect' Stock Picks